Marketing-authorisation holder
Abbott
60 medicines in 1 country, as authorisation holder.
Loading…
Marketing-authorisation holder
60 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 60
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| A-POXIDE10mg | 25mg | 5mg · Capsule | Chlordiazepoxide | United States | Not marketed | 1977 |
| AMINOSYN 3.5% IN PLASTIC CONTAINER3.5% (3.5gm/100ml) · Injectable | Amino acids | United States | Not marketed | |
| AMINOSYN 3.5% M IN PLASTIC CONTAINER3.5%; 21mg/100ml; 40mg/100ml; 128mg/100ml; 234mg/100ml · Injectable | Amino acids, Magnesium acetate, Phosphoric acid, Potassium acetate, Sodium chloride | United States | Not marketed | |
| AMINOSYN 3.5% W/ DEXTROSE 25% IN PLASTIC CONTAINER3.5%; 25gm/100ml · Injectable | Amino acids, Dextrose | United States | Not marketed | |
| AMINOSYN 3.5% W/ DEXTROSE 5% IN PLASTIC CONTAINER3.5%; 5gm/100ml · Injectable | Amino acids, Dextrose | United States | Not marketed | |
| AMINOSYN 4.25% W/ DEXTROSE 25% IN PLASTIC CONTAINER4.25%; 25gm/100ml · Injectable | Amino acids, Dextrose | United States | Not marketed | |
| AMINOSYN-HBC 7% IN PLASTIC CONTAINER7% (7gm/100ml) · Injectable | Amino acids | United States | Not marketed | |
| AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER3.5%; 25gm/100ml · Injectable | Amino acids, Dextrose | United States | Not marketed | 1988 |
| AMINOSYN II 3.5% IN DEXTROSE 5% IN PLASTIC CONTAINER3.5%; 5gm/100ml · Injectable | Amino acids, Dextrose | United States | Not marketed | 1988 |
| AMINOSYN II 3.5% IN PLASTIC CONTAINER3.5% (3.5gm/100ml) · Injectable | Amino acids | United States | Not marketed | |
| AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER3.5%; 5gm/100ml; 30mg/100ml; 97mg/100ml; 120mg/100ml; 49.3mg/100ml · Injectable | Amino acids, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride, Sodium phosphate, Dibasic, Heptahydrate | United States | Not marketed | 1986 |
| AMINOSYN II 3.5% M IN PLASTIC CONTAINER3.5%; 32mg/100ml; 128mg/100ml; 222mg/100ml; 49mg/100ml · Injectable | Amino acids, Magnesium acetate, Potassium acetate, Sodium chloride, Sodium phosphate, Dibasic, Heptahydrate | United States | Not marketed | |
| AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER3.5%; 25gm/100ml; 51mg/100ml; 22.4mg/100ml; 261mg/100ml; 205mg/100ml · Injectable | Amino acids, Dextrose, Magnesium chloride, Potassium chloride, Potassium phosphate, Dibasic, Sodium chloride | United States | Not marketed | 1986 |
| AMINOSYN II 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER4.25%; 10gm/100ml · Injectable | Amino acids, Dextrose | United States | Not marketed | 1988 |
| AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER4.25%; 20gm/100ml · Injectable | Amino acids, Dextrose | United States | Not marketed | 1988 |
| AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER4.25%; 25gm/100ml · Injectable | Amino acids, Dextrose | United States | Not marketed | 1988 |
| AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER4.25%; 10gm/100ml; 30mg/100ml; 97mg/100ml; 120mg/100ml; 49.3mg/100ml | 4.25%; 5gm/100ml; 30mg/100ml; 97mg/100ml; 120mg/100ml; 49.3mg/100ml · Injectable | Amino acids, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride, Sodium phosphate, Dibasic, Heptahydrate | United States | Not marketed | 1986 |
| AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER4.25%; 25gm/100ml; 51mg/100ml; 22.4mg/100ml; 261mg/100ml; 205mg/100ml · Injectable | Amino acids, Dextrose, Magnesium chloride, Potassium chloride, Potassium phosphate, Dibasic, Sodium chloride | United States | Not marketed | 1986 |
| AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINER5%; 25gm/100ml · Injectable | Amino acids, Dextrose | United States | Not marketed | 1986 |
| BRETYLIUM TOSYLATE IN DEXTROSE 5%200mg/100ml | 400mg/100ml | 800mg/100ml · Injectable | Bretylium tosilate | United States | Not marketed | 1986 |
| CEPHALOTHIN SODIUM1gm base/vial | 2gm base/vial | 4gm base/vial · Injectable | Cefalotin | United States | Not marketed | |
| CYLERT37.5mg · Tablet, chewable | Pemoline | United States | Not marketed | 1976 |
| CYLERT18.75mg | 37.5mg | 75mg · Tablet | Pemoline | United States | Not marketed | 1975 |
| DEPAKOTE CP250mg base | 500mg base · Tablet, delayed release | Divalproex | United States | Not marketed | 1990 |
| DEPAKOTE ER250mg | 250mg valproic acid | 500mg | 500mg valproic acid · Tablet, Extended Release | Divalproex | United States | Marketed | 2000 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 60 | 60 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Keep Abbott’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callOther companies in the same group.